Andre Pernet has become the president of Quark Biotech. Pernet previously served as corporate officer and vice president, pharmaceutical products R&D at Abbott Laboratories. He was also chairman and CEO of the European genomic company Genset from 2000 to 2002. He is currently chairman of CURx Pharma and he also serves on the board of directors of Kaleidos Pharmaceuticals.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.